VL Logo

Bone Dense Calcium
Jean Ross Knee Replacement
How To Get What You Want from the HMO
Subnormal Temperature
Karl Loren's Hip Surgery

 

Vibrant Life Home Web
All VL Products
Family Of Three Chelation Formulas
Oral Chelation Ingredient Comparisons

The Wednesday Letter
Karl Loren Viewpoints
Frequently Asked Questions
Testimonials

Free Radicals
Central Page For 18 Web Sites
Vibrant Life Home Page

Shopping Cart

Separate Search Page
or search below


Navigation Help Ingredients Technical Write To Karl Loren Table Of Contents

Viscosupplementation Can Relieve Pain & Protect Your Knee
 

Source

 
Viscosupplementation Can Relieve Pain & Protect Your Knee
byDennis Armstrong, M.D.
   We bend our knees a million times in a year. The lubricating fluid, called synovial fluid, helps this process acting like a lubricant and shock absorber to protect your knee. To understand viscosupplemention and its benefits, let's take a look at the normal knee and osteoarthritis (OA).

   The knee joint is where the femur (thigh bone) and tibia (shin bone) come together. A third bone, the triangular-shaped patella (kneecap), lies across the front of the joint to protect it. As in our other joints, a layer of protective cartilage covers the ends of the bones to allow smooth movement. Special to the knee are two pads of protective tissue called menisci. The entire joint is encased is a capsule lined with a membrane called the synovium which generates a fluid that acts as both a lubricant and a shock absorber. This fluid is called synovial fluid. Various ligaments and muscles support, stabilize and power the joint.

   Although there are many problems associated with knee pain, the most prevalent joint disorder is osteoarthritis. Osteoarthritis can be due to a predisposition to its development but also often is a result of repetitive micro traumas over many years, an injury left untreated such as a torn meniscus and being overweight. The end result of osteoarthritis of the knee is often severe cartilage loss resulting in significant pain particularly while weight bearing (walking), getting up from a chair and sometimes at night.

   Through this process of progressive osteoarthritis, the components of the synovial fluid often breakdown, resulting in diminished shock absorbing characteristics. This loss of shock absorption results in less protection of the knee during movement. One such component of the synovial fluid is hyaluronic acid (HA), which is responsible for the synovial fluid's ability to lubricate and act as a shock absorber in the knee. When one has knee OA, the concentration of HA in the synovial fluid is reduced causing a loss of shock absorbing and lubricating properties. This results in increased joint pain, stiffness and possibly an onset or worsening of osteoarthritis.

What is Hyaluronic Acid?
   Hyaluronic acid (HA) is a substance natural in the body and is present not only in the synovial fluid but also in the eyeballs, skin and cartilage. When isolated, it is a thick, viscous solution. Viscosupplements, which are designed to replace osteoarthritic synovial fluid with a more normal prosthetic synovial fluid, use purified HA derived from either rooster combs or genetically engineered cells to add to the natural HA in the knee joint.

The Role of Viscosupplementation
   Viscosupplementation is an option of treatment for those with moderate to moderately severe osteoarthritis of the knee. Through a series of injections, supplemental HA can be added to the knee joint. It is believed that by replacing the osteoarthritic synovial fluid with a product made of HA that is closer to normal synovial fluid, the patient experiences pain relief due to the presence of a new "lubricant" in the knee that is also acting as a shock absorber. The result is increased protection of the knee joint itself and a soothing of the nerve endings exposed by the degraded cartilage of the osteoarthritic knee.

Could You Benefit?
   Viscosupplementation is given to people with knee osteoarthritis who have not responded to traditional therapies, such as oral anti-inflammatory or analgesic medications or exercise. It is also can be considered for those who are trying to delay or simply are not candidates for total knee replacement surgery. This treatment has not been approved for other joints, although there are studies underway for hip arthritis.

How Is It Administered?
   Viscosupplementation therapy is only available through injection into the knee. The injection is given directly into the knee from a point on the side and under the kneecap. Synvisc is a viscosupplementation product that is specifically designed to be closest to healthy young synovial fluid and provides relief that can last for months. It is given in a series of three injections, one each week. It can take up to 12 weeks to take full effect.

Is There Any Risk?
   If you have had any allergic reaction to any hyaluronate preparations or are allergic to poultry products, you are not a candidate for these injections. You also should not receive these injections if you have an infection or skin disease around the injection area. Sometimes one can experience some swelling, heat, redness or itching around the joint, but this is temporary. Any reaction is usually mild and short-lived.

Does Viscosupplemention Work?
   HA viscosupplemention is a safe and effective treatment for osteoarthritis of the knee. Depending on the severity of the knee arthritis, these injections can be 72-75% effective for six months to a year.

   If you wonder whether you are a candidate or could benefit from viscosupplemention, see your orthopaedic surgeon or rheumatologist for an evaluation of your options.

About the Author:
   Arizona orthopaedic surgeon, Dennis Armstrong, M.D., is board certified in orthopaedic surgery and specializes in arthritis reconstructive surgery. He received his medical degree from the Wayne State School of Medicine and completed his orthopaedic residency at Henry Ford Hospital in Detroit, Michigan. Dr. Armstrong has been involved in several clinical investigative studies researching the surgery and care of those undergoing total joint replacement, and has authored numerous talks/papers on options for knee and hip pain.

 

© Copyright 2002. Arthritis Education by Professionals, Inc.


Source

Today's News

Friday, February 5, 1999

 

Viscosupplementation found useful for osteoarthitis pain

Edward H. Miller, MD, principal exhibitor, assistant volunteer professor, department of orthopaedics, University of Cincinnati College of Medicine, and colleagues said viscosupplementation is useful in patients who fail NSAID and intra-articular corticosteroid injection. Benefits are radiological grade dependent, being less effective in the higher (worse) grades of osteoarthritis.

The authors said viscosupplementation has been shown to be superior to continuous NSAID therapy and can delay the necessity of total knee replacement in up to one-third of patients. There is a significantly higher incidence of adverse effects of acute inflammatory reaction than previously reported; these are self-limiting.

Sixteen patients, who received a series of five injections with hyaluronan, were compared to 92 patients receiving three injections of Hylan G-F 20 at one week intervals. The standard dose of 2 ccs. was used in all cases. The patients included 52 men and 56 women. The average age was 62 years. The average follow-up was 1.3 years (range: 12 to 18 months). The patients had radiological Stages I through IV in at least one compartment of the knee. All patients had failed control of symptoms with NSAIDs and intra-articular corticosteroids.

All knees with effusions at the initial injection were aspirated. The Hospital for Special Surgery knee rating scale and the SF-36 surveys were performed pretreatment, at one-month, 12-weeks, 26-weeks and one-year posttreatment. Results and degree of improvement shown by the HSS Scale were correlated with the radiological stage of osteoarthritis.

The most significant adverse effect, which occurred in 7.4 percent of the patients, was an acute inflammatory reaction that can occur at any time up to 10 days after any of the three injections. It was characterized by severe pain and marked effusion. Treatment consisted of serial arthrocenteses for culture and analysis, analgesics and antiinflammatory medications. A short course of antibiotics was prescribed until the bacteriological studies were determined to be negative (all were negative).

Joint fluid analysis revealed high polymorphonuclear leukocyte counts (ranging from 9,000 to 28,000), a normal mucin clot test, normal glucose and a normal string test. Resolution is spontaneous, occurring in three to seven days and did not jeopardize the ultimate results of the treatment. Two patients required treatment with short course systemic prednisone (six day decreasing dose).

In addition to Dr. Miller, study co-authors, all of the department of orthopaedics, University of Cincinnati College of Medicine, are Mark A. Snyder, MD, assistant volunteer professor; Robert S. Heidt Jr., MD, assistant volunteer professor; and Michael Welch, MD, associate clinical professor.

 

 

 


Source

 
J Bone Joint Surg Am 2002 Jul;84-A(7):1142-7  
Click here to read 
Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee : a report of six cases.

Chen AL, Desai P, Adler EM, Di Cesare PE.

Department of Orthopaedic Surgery, New York University-Hospital for Joint Diseases, New York, NY 10003, USA.

BACKGROUND: Recently, intra-articular viscosupplementation with hyaluronate-derived products has gained popularity as a palliative modality for the treatment of osteoarthritis of the knee. Mild pain or swelling at the site of injection may occur in up to 20% of patients, although severe local inflammation, warmth, and joint effusion are rare. We present a series of six cases in which granulomatous inflammation of the synovium was observed after hyaluronate viscosupplementation of the knee. METHODS: Six knees (five patients) treated with intra-articular Hylan G-F 20 viscosupplementation underwent a surgical procedure because of persistent symptoms. Routine histopathological evaluation, supplemented by alcian-blue staining and hyaluronidase digestion, was performed in each case. RESULTS: Chronically inflamed synovium with areas of histiocytic and foreign-body giant-cell reaction was observed surrounding acellular, amorphous material. The material stained with alcian blue, a stain for hyaluronate, which disappeared after hyaluronidase digestion. CONCLUSIONS: We believe that the injected hyaluronate (Hylan G-F 20) may have been responsible for the synovitis in our patients and thus may be a pathological cause of recalcitrant symptoms after such injection. It is not known whether the responsible pathological agent was the hyaluronate derivative, a contaminant of the purification process, or a component of the carrier substance. Importantly, it appears that the findings in these patients most likely represent a previously unreported pathological response to a viscosupplementation product. This report should raise clinical awareness about this potential complication.

PMID: 12107313 [PubMed - indexed for MEDLINE]

Source
Drug Saf 2000 Aug;23(2):115-30  

A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee.

Adams ME, Lussier AJ, Peyron JG.

Department of Medicine, University of Calgary and McCaig Centre for Joint Injury and Arthritis Research, Alberta, Canada. adams@ucalgary.ca

Hyaluronan is critical for the homeostasis of the joint as an organ, in part, because it provides the rheological properties (viscosity and elasticity) of the synovial fluid. These properties depend upon both the concentration and the molecular weight of the hyaluronan in the synovial fluid. In osteoarthritis, the hyaluronan is both smaller in size and lower in concentration. Thus, it is rational and physiologically meaningful to treat osteoarthritis with viscosupplementation, i.e. injection of material designed to increase the rheological properties of the synovial fluid. It is important, though, to assess the risks and benefits of such a physiological treatment. There are various products on the market for viscosupplementation. These include hyaluronan preparations of relatively low molecular weight (Hyalgan and ARTZ), a hyaluronan preparation of intermediate molecular weight, but still lower molecular weight than that of the hyaluronan in normal healthy synovial fluid (Orthovisc), and a cross-linked hyaluronan (a hylan) of high molecular weight (Synvisc). The evidence from in vitro and in vivo models of osteoarthritis and from clinical trials to date suggests that efficacy, as would be expected by mechanistic reasoning, depends strongly upon molecular weight. The available evidence indicates that these products differ little in the incidence and severity of adverse events (about 2 to 4%, almost always local swelling, and with no adverse sequelae). All are very well tolerated in comparison to nonsteroidal anti-inflammatory drug therapy, although direct comparisons are few. The only potentially serious adverse event is joint infection, which is rare and directly dependent upon the number of injections, among other factors. No infection has been related to contamination of any of the products. In summary, treatment with low molecular weight preparations of hyaluronan seems to be effective. However, viscosupplementation with hyaluronan preparations may have slightly higher risk and less benefit than viscosupplementation with hylans, because the relatively lower molecular weight hyaluronan preparations require more injections which may incur higher costs and theoretically an increased chance of infection. Viscosupplementation with hylans is clearly effective, and the available evidence suggests that the benefits almost certainly outweigh the risks.

Publication Types:


PMID: 10945374 [PubMed - indexed for MEDLINE]


 

 

 

 


 

 



Special Pages On The Various of Web Sites Authored by Karl Loren
OC History Oral Chelation Testimonials
Family Of Three Oral Chelation Formulas Life Glow Basic Life Glow Basic Ingredient List
Life Glow Plus Life Glow Plus
Ingredient List
American Heart Association -- Lies
Super Life Glow Super Life Glow
 Ingredient List
FAQ
All Products Shopping Cart Order Section Research
Taheebo Life Tea Witch Doctors Versus Harvard MSM Sulfur
Calcium How Bones Grow Colloidal Minerals
Jean Ross Philosophy The Wednesday Letter
Arthritis & James Coburn's Use Of MSM Karl Loren Viewpoints News And Announcements
Dr. Flanagan's Microhydrin 500 Page Book On Heart Disease Colostrum & Transfer Factor
Germanium Ultrasound Technology Bulk MSM
Cancer & Biopsy Diabetes Heart Disease & Bypass Surgery
Karl Loren's Diet Guarantee Navigation Help Page
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Immune Egg Central Page For All Web Sites!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 

SUBSCRIBE:  The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.  You can view more than 50 back issues of this publication by clicking here.  The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  It is automatically published on the Tuesday night just before the first Wednesday of every month.  You can subscribe to this free monthly electronic letter by entering your eMail address and name below.  You will then automatically receive a request for confirmation, sent to whatever address you have entered.  If you do NOT receive this confirmation request, then you will not be subscribed.  There may have been an error with your address and you should resubmit.  The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.  When you receive this confirmation request you must reply to it, or your subscription will not become active.  No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.

You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 20, 2008 6:23 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.